＜Research＞Citi Opens Upside 30-day Catalyst Watch on SINO BIOPHARM (01177.HK)

AASTOCKS

2024-07-26 11:21

Citi Research issued a research report expecting SINO BIOPHARM (01177.HK) to post intact 1H24 results, with earnings expected to grow by about 10% YoY...

　　Citi Research issued a research report expecting SINO BIOPHARM (01177.HK) +0.030 (+1.087%) Short selling $19.73M; Ratio 21.373% to post intact 1H24 results, with earnings expected to grow by about 10% YoY due to strong sales growth of biosimilar and innovative drugs.

　　Higher visibility is expected in the Company's 2H24 results on increased sales of biosimilar, G-CSF and Cataplasms.

　　Citi Research opened an upside 30-day catalyst watch on SINO BIOPHARM, with a target price of $6.8 and rating at Buy.

　　(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-07-25 16:25.)

　　AAStocks Financial News

Disclaimer:The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

Latest News

Promoting the development of lithium and sodium in the new energy industry